InvestorsHub Logo
Followers 59
Posts 2267
Boards Moderated 0
Alias Born 02/13/2016

Re: jfmcrr post# 103244

Thursday, 03/23/2017 5:57:50 PM

Thursday, March 23, 2017 5:57:50 PM

Post# of 424006

It comes down to whether or not the early halt is required or allowed.



Stopping for efficacy is not required. There are many reasons to continue even if the efficacy data are great.

I don't recall who said it (perhaps Pocock) but:

"The question a DSMB faces is not can we stop, but should we stop."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News